Related Experiment Video
Updated: Jun 17, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
A decrease in serum aldosterone level is associated with maintenance of sinus rhythm after successful cardioversion
Beata Wozakowska-Kaplon1, Radoslaw Bartkowiak, Grazyna Janiszewska
11st Clinical Department of Cardiology, Swietokrzyskie Centre of Cardiology in Kielce, Kielce, Poland. bw.kaplon@poczta.onet.pl
Insights
Successful cardioversion of atrial fibrillation (AF) is linked to a significant drop in aldosterone levels. A decrease in aldosterone post-cardioversion predicts maintaining sinus rhythm, aiding AF management.
Area of Science:
- Cardiology
- Endocrinology
- Internal Medicine
Background:
- The renin-angiotensin-aldosterone system's role in atrial fibrillation (AF) progression is known.
- Aldosterone's specific impact on AF structural remodeling requires further investigation.
Purpose of the Study:
- To assess serum aldosterone concentration changes after successful cardioversion of persistent AF.
- To determine the prognostic significance of aldosterone level fluctuations post-cardioversion.
Main Methods:
- Prospective study of 45 patients with nonvalvular persistent AF undergoing cardioversion.
- Serum aldosterone levels measured 24 hours before and 24 hours after cardioversion.
- Patients were categorized based on sinus rhythm maintenance at 30 days post-cardioversion.
Main Results:
- Forty-three patients were successfully cardioverted; 24 maintained sinus rhythm (Group A), 19 relapsed (Group B).
- Group A showed a significant aldosterone decrease (175.6 to 101.4 pg/mL) post-cardioversion (P=0.0034).
- Aldosterone decrease >13.2 pg/mL predicted sinus rhythm maintenance with 87% sensitivity and 64% specificity.
Conclusions:
- A significant fall in aldosterone concentration 24 hours post-cardioversion correlates with sustained sinus rhythm.
- Aldosterone level changes offer prognostic value for AF recurrence after cardioversion.
Background:
The activation of the renin-angiotensin-aldosterone system has been implicated in the progression of atrial structural remodeling during atrial fibrillation (AF). However, consequences of the changes of aldosterone in AF have not been evaluated.
Objectives:
This study's aim was to evaluate changes of serum aldosterone concentration after successful cardioversion of persistent AF and to determine the prognostic value of these changes.
Methods:
The prospective, single center study included 45 consecutive patients with nonvalvular persistent AF and preserved left ventricular systolic function, referred for cardioversion. None of the patients were taking aldosterone antagonists. Blood samples for aldosterone measurement were collected twice: 24 hours before and 24 hours after cardioversion.
Results:
Forty-three patients were successfully converted to sinus rhythm. On the 30th day following cardioversion, 24 patients maintained sinus rhythm (group A), 19 patients relapsed to AF (group B). Serum aldosterone concentration before cardioversion did not differ significantly between both groups (175.6 +/- 112.82 pg/mL vs 125.8 +/- 51.2 pg/mL; P = 0.25). However, in group A serum aldosterone level decreased significantly within 24 hours after cardioversion, from 175.6 +/- 112.8 pg/mL to 101.4 +/- 44.2 pg/mL (P = 0.0034). In group B, the aldosterone level before and after cardioversion did not differ significantly (125.8 +/- 51.2 pg/mL vs 118.2 +/- 59.6 pg/mL; P = 0.68). Logistic regression analysis revealed that a decrease in plasma aldosterone concentration after direct current cardioversion more than 13.2 pg/mL predicted sinus rhythm maintenance in a 30-day follow-up, with 87% sensitivity and 64% specificity.
Conclusions:
There is a positive correlation between the fall in aldosterone concentration 24 hours after cardioversion and maintenance of sinus rhythm during 30 days of observation.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Dysrhythmias VI: Management of Dysrhythmias
Antihypertensive Drugs: Direct Renin Inhibitors
ECG Interpretation of Arrhythmias I: Sinus Arrhythmias
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism, and...

